Drug
Sabizabulin clinical trials
Also written VERU-111.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Veru Inc. (6)
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic Agents source
Studies
Open first, then newest update. How each study uses sabizabulin is read from its arms, and is right about nine times in ten.
Testing it · 6
- VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on StudyCompletedPhase 3Veru Inc.NCT04842747Written as VERU-111
- Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentTerminatedPhase 3Veru Inc.NCT04844749Written as VERU-111
- To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerTerminatedPhase 1/2Veru Inc.NCT03752099Written as VERU-111
- Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerWithdrawnPhase 2Veru Inc.NCT05079360Written as Sabizabulin
- COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111CompletedPhase 2Veru Inc.NCT04388826Written as Veru-111
- P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .WithdrawnPhase 2Veru Inc.NCT05008510Written as Sabizabulin
Codes
What other systems call sabizabulin · ClinicalTrials.gg INT001405
- MeSH (NLM) C000710140sabizabulinOne source NLM
- UNII (FDA) 37L1JX37J5SABIZABULINConfirmed FDA, NLM, Wikidata
- Wikidata Q111600344sabizabulinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C158517SabizabulinOne source FDA
- DrugBank DB16462One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000710140 | sabizabulin | One source NLM |
| UNII (FDA) | 37L1JX37J5 | SABIZABULIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q111600344 | sabizabulin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C158517 | Sabizabulin | One source FDA |
| DrugBank | DB16462 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.